Tom Price

President Donald Trump’s ever-contracting cabinet lost another member Friday with a fresh vacancy in health and human services. Tom Price will fly home stripped of his title after fallout over his extravagant spending on taxpayer-funded private plane travel. Trump received Price’s...

The U.S. Food and Drug Administration's quest to address the growing opioid crisis is hurting many pharmaceutical companies, including Endo International plc - Ordinary Shares (NASDAQ: ENDP), presenting an opportunity for companies like Alkermes Plc (NASDAQ: ALKS), which makes treatments for opioid...

Even before Donald Trump is inaugurated as president, a scandal has come to rock the incoming regime. A CNN report has revealed that Rep. Tom Price, Trump's nominee for Health and Human Services secretary has unethically bought shares in Zimmer Biomet Holdings Inc (NYSE: ZBH) days ahead of...

KeyBanc Capital’s Donald Hooker expects the Investor Summit hosted by athenahealth, Inc (NASDAQ: ATHN) on December 15 to include discussions on two “promising” verticals, hospitals and population health management. Hooker maintains a Sector Weight rating on the company....

Chris Meekins, an analyst at FBR, was a guest on CNBC's "Halftime Report" segment on Wednesday and offered three reasons why pharmaceutical investors should brush off President-elect Donald Trump's comments that he is "going to bring down drug prices." 3 Reasons First, Meekins argued what is more...